Friedli, Christoph Daniel

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2023 | 2022 | 2021 | 2020 | 2019

2023

Rebsamen, Michael; McKinley, Richard; Radojewski, Piotr; Pistor, Maximilian; Friedli, Christoph; Hoepner, Robert; Salmen, Anke; Chan, Andrew; Reyes, Mauricio; Wagner, Franca; Wiest, Roland; Rummel, Christian (2023). Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosis. Human brain mapping, 44(3), pp. 970-979. Wiley-Blackwell 10.1002/hbm.26117

Rebsamen, Michael; Friedli, Christoph; Radojewski, Piotr; Diem, Lara; Chan, Andrew; Wiest, Roland; Salmen, Anke; Rummel, Christian; Hoepner, Robert (2023). Multiple sclerosis as a model to investigate SARS‐CoV ‐2 effect on brain atrophy. CNS neuroscience & therapeutics, 29(2), pp. 538-543. Wiley 10.1111/cns.14050

Friedli, Christoph; Wagner, Franca; Hammer, Helly Noemi; Kamber, Nicole; Wiest, Roland; Diem, Lara; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2023). Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients. Multiple sclerosis journal, 29(1), pp. 63-73. Sage 10.1177/13524585221122210

Friedli, Christoph; Salmen, Anke; Hoepner, Robert; Achtnichts, Lutz; Bigi, Sandra; Derfuss, Tobias; Gobbi, Claudio; Kamber, Nicole; Kamm, Christian P; Kuhle, Jens; Lalive, Patrice; Müller, Stefanie; Papadopoulou, Athina; Pot, Caroline; Zecca, Chiara; Chan, Andrew (2023). Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022. Clinical and translational neuroscience, 7(1), p. 2. MDPI 10.3390/ctn7010002

2022

Diem, Lara; Schwarzwald, Anina; Friedli, Christoph; Hammer, Helly; Gomes-Fregolente, Livia; Warncke, Jan; Weber, Lea; Kamber, Nicole; Chan, Andrew; Bassetti, Claudio; Salmen, Anke; Hoepner, Robert (2022). Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study. CNS neuroscience & therapeutics, 28(12), pp. 1953-1963. Wiley 10.1111/cns.13938

Diem, L; Evangelopoulos, M E; Karathanassis, D; Natsis, V; Kamber, N; Hammer, H; Friedli, C; Chan, A; Helbling, A; Penner, I K; Salmen, A; Walther, S; Stegmayer, K; Hoepner, R (2022). Hypogammaglobulinemia: A contributing factor to multiple sclerosis fatigue? Multiple Sclerosis and Related Disorders, 68, p. 104148. Elsevier 10.1016/j.msard.2022.104148

Schwarzwald, A; Salmen, A; Léon Betancourt, A; Diem, L; Hammer, H; Radojewski, P; Rebsamen, M; Kamber, N; Chan, A; Hoepner, R; Friedli, C (2022). Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia - a case report and review of the literature. (In Press). European journal of neurology Wiley 10.1111/ene.15648

Hammer, H; Kamber, N; Pistor, M; Diem, L; Friedli, C; Chan, A; Hoepner, R; Salmen, A (2022). Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS). Multiple Sclerosis and Related Disorders, 65, p. 104015. Elsevier 10.1016/j.msard.2022.104015

Hoepner, Robert; Kamm, Christian; Friedli, Christoph; Salmen, Anke; Chan, Andrew (2022). Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? CNS neuroscience & therapeutics, 28(6), pp. 971-973. Wiley 10.1111/cns.13841

Hammer, Helly; Kamber, Nicole; Friedli, Christoph; Hoepner, Robert; Diem, Lara; Chan, Andrew; Salmen, Anke (2022). [Primary CNS Vasculitis - An Overview]. Therapeutische Umschau. Revue therapeutique, 79(5), pp. 247-253. Huber 10.1024/0040-5930/a001358

Diem, Lara; Fregolente-Gomes, Livia; Warncke, Jan D; Hammer, Helly; Friedli, Christoph; Kamber, Nicole; Jung, Simon; Bigi, Sandra; Funke-Chambour, Manuela; Chan, Andrew; Bassetti, Claudio L; Salmen, Anke; Hoepner, Robert (2022). Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19. Journal of central nervous system disease, 14, p. 11795735221102727. Sage 10.1177/11795735221102727

Pistor, Maximilian; Hammer, Helly; Salmen, Anke; Hoepner, Robert; Friedli, Christoph (2022). Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort. CNS neuroscience & therapeutics, 28(5), pp. 792-795. Wiley 10.1111/cns.13806

Hammer, H; Salmen, A; Kamber, N; Friedli, Chr; Diem, L; Hoepner, R; Chan, A (January 2022). Primäre ZNS-Vaskulitis. Rheuma Schweiz Fachzeitschrift, 2022(1), pp. 46-54.

Hammer, Helly; Hoepner, Robert; Friedli, Christoph; Leib, Stephen L; Suter-Riniker, Franziska; Diem, Lara; Kamber, Nicole; Chan, Andrew; Salmen, Anke; Kamm, Christian P (2022). Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients. Vaccines, 10(6), p. 922. MDPI 10.3390/vaccines10060922

2021

Diem, Lara; Friedli, Christoph; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2021). Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge. Neurology: Neuroimmunology and Neuroinflammation, 8(3) Wolters Kluwer Health 10.1212/NXI.0000000000000991

Diem, L.; Hoepner, R.; Bagnoud, M.; Salmen, A.; Chan, A.; Friedli, C. (2021). Natalizumab induced blood eosinophilia: A retrospective pharmacovigilance cohort study and review of the literature. Journal of neuroimmunology, 353, p. 577505. Elsevier 10.1016/j.jneuroim.2021.577505

Veselaj, Krenar; Kamber, Nicole; Briner, Myriam; Friedli, Christoph; Diem, Lara; Guse, Kirsten; Miclea, Andrei; Wiest, Roland; Wagner, Franca; Grabe, Hilary; Abegg, Mathias; Horn, Michael P.; Bigi, Sandra; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2021). Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort. CNS neuroscience & therapeutics, 27(4), pp. 426-438. Wiley 10.1111/cns.13461

Friedli, Christoph; Diem, Lara; Hammer, Helly; Kamber, Nicole; Suter-Riniker, Franziska; Leib, Stephen; Chan, Andrew; Hirzel, Cédric; Hoepner, Robert; Salmen, Anke (2021). Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies. Therapeutic advances in neurological disorders, 14, p. 17562864211016641. Sage 10.1177/17562864211016641

Chaloulos-Iakovidis, Panagiotis; Wagner, Franca; Weber, Lea; Diem, Lara; Chan, Andrew; Salmen, Anke; Friedli, Christoph; Hoepner, Robert (2021). Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study. Therapeutic advances in neurological disorders, 14, p. 17562864211030664. Sage 10.1177/17562864211030664

2020

McKinley, Richard; Wepfer, Rik; Grunder, Lorenz; Aschwanden, Fabian; Fischer, Tim; Friedli, Christoph; Muri, Raphaela; Rummel, Christian; Verma, Rajeev Kumar; Weisstanner, Christian; Wiestler, Benedikt; Berger, Christoph; Eichinger, Paul; Muehlau, Mark; Reyes, Mauricio; Salmen, Anke; Chan, Andrew; Wiest, Roland; Wagner, Franca (2020). Automatic detection of lesion load change in Multiple Sclerosis using convolutional neural networks with segmentation confidence. NeuroImage: Clinical, 25, p. 102104. Elsevier 10.1016/j.nicl.2019.102104

2019

Briner, Myriam; Bagnoud, Maud; Miclea, Andrei; Friedli, Christoph; Diem, Lara; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2019). Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age. Therapeutic advances in neurological disorders, 12, p. 1756286419843450. Sage 10.1177/1756286419843450

Maeder, Cecilia; Friedli, Christoph; Kuchen, Stefan; Wiest, Roland; Hewer, Ekkehard; Rovó, Alicia; Chan, Andrew (2019). Langerhans cell histiocytosis with initial central nervous system presentation as a mimic of neurosarcoidosis. Clinical and translational neuroscience, 3(2), 2514183X1987506. Sage Publications 10.1177/2514183x19875064

Zoehner, Greta; Miclea, Andrei; Salmen, Anke; Kamber, Nicole; Diem, Lara; Friedli, Christoph; Bagnoud, Maud; Ahmadi, Farhad; Briner, Myriam; Sédille-Mostafaie, Nazanin; Kilidireas, Constantinos; Stefanis, Leonidas; Chan, Andrew; Hoepner, Robert; Evangelopoulos, Maria Eleftheria (2019). Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course. Therapeutic advances in neurological disorders, 12, p. 1756286419878340. Sage 10.1177/1756286419878340

McKinley, Richard; Grunder, Lorenz; Wepfer, Rik; Aschwanden, Fabian; Fischer, Tim; Friedli, Christoph; Muri, Raphaela; Rummel, Christian; Verma, Rajeev; Weisstanner, Christian; Reyes, Mauricio; Salmen, Anke; Chan, Andrew; Wiest, Roland; Wagner, Franca (2019). Automatic detection of lesion load change in Multiple Sclerosis using convolutional neural networks with segmentation confidence (arXiv). Cornell University

Provide Feedback